Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 4/20 | 0.52 |
| ▸ | CYP2B6 | P20813 | 2/20 | 0.52 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.52 |
| ▸ | PTPRC | P08575 | 1/20 | 0.44 |
| ▸ | CDK8 | P49336 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | KDR | P35968 | 1/20 | 0.40 |
| ▸ | TDO2 | P48775 | 1/20 | 0.39 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.37 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.37 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.37 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.37 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.37 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.37 |
| ▸ | NQO2 | P16083 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30165237 | 1.00 | CYP2A6 (0.52) | CYP2A6CYP2B6CYP2E1PTPRCCDK8 | |
| SCHEMBL4946960 | 0.84 | CYP2A6 (0.64) | CYP2A6CYP2B6CYP2E1PTPRCCDK8 | |
| SCHEMBL7058734 | 0.77 | CYP2A6 (0.70) | CYP2A6CYP2B6CYP2E1PTPRCCDK8 | |
| SCHEMBL3181535 | 0.76 | CYP2A6 (0.54) | CYP2A6CYP2B6CYP2E1PTPRCCDK8 | |
| SCHEMBL27870289 | 0.76 | CYP2A6 (0.67) | CYP2A6CYP2B6CYP2E1PTPRCCDK8 | |
| SCHEMBL26259994 | 0.75 | CYP2A6 (0.52) | CYP2A6CYP2B6CYP2E1PTPRCCDK8 | |
| SCHEMBL26259978 | 0.75 | CYP2A6 (0.58) | CYP2A6CYP2B6CYP2E1PTPRCCDK8 | |
| SCHEMBL1310377 | 0.74 | ALDH1A1 (0.54) | CYP2A6CYP2B6CYP2E1PTPRCCDK8 | |
| SCHEMBL1309148 | 0.74 | CYP2A6 (0.54) | CYP2A6CYP2B6CYP2E1PTPRCCYP3A4 | |
| SCHEMBL5190739 | 0.74 | ALDH1A1 (0.54) | CYP2A6CYP2B6CYP2E1PTPRCCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115745805-A | Synthetic method of phenanthrene and naphthocycloheptene compounds | 南通大学 | 2023-03-07 | — | — | CN | claimed |
| CN-115745805-A | Synthetic method of phenanthrene and naphthocycloheptene compounds | 南通大学 | 2023-03-07 | — | — | CN | disclosed |
| CN-100357274-C | Diaryl-enynes | NPS ALLELIX CORP (CA) | 2007-12-26 | — | — | CN | disclosed |
| EP-1226108-A4 | DIARYL-ENYNES | NPS ALLELIX CORP (CA) | 2004-06-16 | — | — | EP | disclosed |
| US-6579987-B2 | Reducing an ester containing ene-yne conjugated, silane and aryl or heteroaryl functionality to an alcohol; bromination, amination, desilanation, coupling and deprotecting | NPS ALLELIX CORPORATION (CA) | 2003-06-17 | — | — | US | disclosed |
| US-20030092769-A1 | DIARYL-ENYNES | NPS ALLELIX CORPORATION (CA) | 2003-05-15 | — | — | US | disclosed |
| US-6525085-B2 | Treating neurological and neuropsychiatric disorders | NPS ALLELIX CORP. (CA) | 2003-02-25 | — | — | US | disclosed |
| CN-1387507-A | diaryl enynes | NPS ALLELIX CORP (CA) | 2002-12-25 | — | — | CN | disclosed |
| US-20020169197-A1 | Diaryl-enynes | NPS ALLELIX CORP. | 2002-11-14 | — | — | US | disclosed |
| EP-1226108-A1 | DIARYL-ENYNES | NPS Allelix Corp. (CA) | 2002-07-31 | — | — | EP | disclosed |
| US-6426364-B1 | NERVOUS SYSTEM OR PSYCHOLOGICAL DISORDERS | NPS ALLELIX CORP. (CA) | 2002-07-30 | — | — | US | disclosed |
| WO-2001032602-A1 | DIARYL-ENYNES | NPS ALLELIX CORP. (CA) | 2001-05-10 | — | — | WO | disclosed |
| CN-1023699-C | Difluoromethyl compounds | MERCK PATENT GMBH (DE) | 1994-02-09 | — | — | CN | disclosed |
| CN-1039797-A | difluoromethyl compound | MERCK PATENT GMBH (DE) | 1990-02-21 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020169197-A1 | Diaryl-enynes | CBR3, CNR1, NR3C2 | CYP2A6 1020/4885CYP2B6 1044/4885CYP2E1 306/4885 |
| US-20030092769-A1 | DIARYL-ENYNES | CBR3, CNR1, CBR1 | CYP2A6 1060/4885CYP2B6 1084/4885CYP2E1 315/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.